| Description | Darapladib-impurity is the impurity of Darapladib. Darapladib inhibits lipoprotein-associated phospholipase A2 (Lp-PLA2). |
| molecular weight | 666.77 |
| Molecular formula | C36H38F4N4O2S |
| CAS | 1389264-17-8 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
| Solubility | DMSO: 1 mg/mL, Sonication is recommended. |
| References | 1. Moneeza K Siddiqui, et al.Diabetes status modifies the long-term effect of lipoprotein-associated phospholipase A2 on major coronary events.Clinical Trial Diabetologia. 2022 Jan;65(1):101-112. |